Piramal Pharma Solutions names John Fowler as its COO

Mumbai: Piramal Pharma Solutions (PPS), part of Piramal Enterprises Limited, announced the appointment of John Fowler as its Chief Operating Officer. PPS offers a comprehensive range of services including Drug Discovery Solutions, Process & Pharmaceutical Development services, Clinical Trial Supplies and Commercial supply of APIs and Finished dosage forms. As Chief Operating Officer, John will be responsible for Global Operations and Research & development (R&D), and will play a lead role in ensuring that our customers consistently experience differentiated and excellent levels of service.

In announcing the appointment, Vivek Sharma, CEO, Piramal Pharma Solutions, said “As PPS enters into the next phase of its rapid growth, it is important that we bring in seasoned executives with international experience and expertise. Over a distinguished career of nearly three decades, John has successfully led several global businesses, streamlined operations, developed and implemented commercial strategies that have increased profitability while driving growth, and has aligned focus of R&D team with long term business requirements. With our customers increasingly choosing Piramal as their ‘Partner of Choice’ to progress their assets from discovery towards commercialization, John’s track record of aligning services and talent towards a common vision, is one that the PPS team can benefit from. We are excited to have John as part of our Leadership team, welcome him, and look forward to his contributions in building strategic partnerships with our customers and propel PPS forward into the next decade”.